A WOKINGHAM-based label management solution company has welcomed a new director for its clinical trial sales in North America.
Robert Bowdish has signed up to the Oaklands Park-based company to help boost its operations on the other side of the pond.
He started as a pharmaceutical sales representative 26 years ago and spent the last decade specialising in regulatory and clinical software solutions and services market.
He has joined PRISYM ID from Parexel Informatics, where he was initially senior director for solutions consulting, becoming senior director for regulatory clinical solutions, global sales, where he led a team of sales directors working across diverse sectors.
Warren Stacey, senior vice-president of sales at PRISYM ID, was delighted with the new appointment.
“Robert is a fantastic addition to our team at PRISYM ID,” he said.
“He will take the lead driving Clinical Trials Sales in the North American market, building on his relationships with pharma and CROs, demonstrating how our market-leading products can be integrated into a clinical trial supply chain to deliver a compliant labelling solution.”